Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Microsure logo — Robot-assisted microsurgery

Microsure

Robot-assisted microsurgery

Founded 2016 The Netherlands The Netherlands 61 employees Series B Total: $42.51M Health Care, Medical Devices

General Information

Company Name Microsure
Founded Year 2016
Location The Netherlands The Netherlands
Founders / Decision Makers
Team member
Employees 61
Industries Health Care, Medical Devices
Funding Stage Series B
Business Model B2B, SaaS
Revenue Model Product Sales, Subscription, Leasing/Rental
Social

BounceWatch is an independent company data service, not affiliated with Microsure. To contact Microsure, visit microsure.nl.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Microsure compare?

A PDF of Microsure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Microsure soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Microsure

Microsure, founded in 2016 and headquartered in The Netherlands, stands out in the Health Care and Medical Devices industries with its pioneering product: robot-assisted microsurgery. The company addresses the intricate challenges faced by supermicrosurgeons, who require precision at sub-millimeter levels, by continuously enhancing their high precision microsurgical robot.

The flagship product, MUSA-2, is celebrated as the first CE certified microsurgical robot, praised for features like scaled movements and tremor filtration. This innovation has been validated through various clinical studies and invaluable feedback has shaped the development of its successor, MUSA-3.

Backed by a robust €38.00M Series B investment on September 19, 2023, Microsystems secured funding from prominent investors, including BOM Brabant Ventures, European Innovation Council, Invest-NL, Kineo Finance, Innovation Industries, Eindhoven University of Technology, Ten Cate Investeringsmaatschappij, and VENTURING TECH. This funding solidifies Microsure's path towards revolutionizing the niche field of microsurgery, ensuring no patient is left without needed treatment.

Business keywords: Robot-assisted Microsurgery, High Precision Robotics, Microsurgical Robots, Medical Device Innovation, Surgical Robotics Development, Tremor Filtration Technology, Ergonomic Surgical Solutions, Supermicrosurgery, Lymphedema Treatment, Motion Stabilization Systems, Surgical Outcomes Improvement, Reconstructive and Plastic Surgery, Advanced Surgical Procedures, MedTech Solutions, Clinical Trial Validation

Services & Products

development of microsurgical robots
enhancing precision in microsurgery
providing ergonomic surgical solutions
improving complex surgical procedures

Target Customers

microsurgeons plastic surgeons reconstructive surgeons medical centers specializing in microsurgery hospitals adopting robotic surgery

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B €38.00M 8
BOM Brabant Ventures European Innovation Council Invest-NL
BOM Brabant Ventures, European Innovation Council +6
19 Sep 2023
Grant €1.81M 1
European Innovation Council
European Innovation Council
16 Jun 2021
Series B €2.70M 1
TCIM
TCIM
29 Apr 2021
Venture Round Undisclosed -
30 Mar 2018

Microsure Alternatives & Competitors

Microsure vs
MMI - Medical Microinstruments, Inc.
MMI - Medical Microinstruments, Inc. United States

Advancing robotic technology for soft tissue open surgery at the micro level

Series C
320 employees
Health Care, Medical Devices
Compare Microsure vs MMI - Medical Microinstruments, Inc.

FAQ About Microsure

Robot-assisted microsurgery
Microsure was founded in 2016.
Microsure is headquartered in The Netherlands.
Microsure operates in Health Care and Medical Devices. Its work centres on Robot-assisted Microsurgery, High Precision Robotics, Microsurgical Robots and Medical Device Innovation. Its customers include microsurgeons, plastic surgeons and reconstructive surgeons.
Microsure has a B2B and SaaS business model. Its revenue comes from Product Sales, Subscription and Leasing/Rental.
Microsure has approximately 61 employees.
Microsure has completed 4 funding rounds, raising a total of $42.51M. The latest funding stage is Series B.
Microsure offers: development of microsurgical robots, enhancing precision in microsurgery, providing ergonomic surgical solutions, improving complex surgical procedures.
Top alternatives and competitors to Microsure include MMI - Medical Microinstruments, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Microsure and MMI - Medical Microinstruments, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Microsure, https://bouncewatch.com/company/microsure, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes